Gene · 2913
Papers2,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acrylamide exposure represses neuronal differentiation, induces cell apoptosis and promotes tau hyperphosphorylation in hESC-derived 3D cerebral organoids. | Food Chem Toxicol | 2020 | 32763439 | PubTator, text mining | PubMed |
| Lysine Deprivation during Maternal Consumption of Low-Protein Diets Could Adversely Affect Early Embryo Development and Health in Adulthood. | Int J Environ Res Public Health | 2020 | 32751190 | PubTator, text mining | PubMed |
| Rapid acting antidepressants in the mTOR pathway: Current evidence. | Brain Res Bull | 2020 | 32739296 | PubTator, text mining | PubMed |
| Site-Specific Incorporation of Genetically Encoded Photo-Crosslinkers Locates the Heteromeric Interface of a GPCR Complex in Living Cells. | Cell Chem Biol | 2020 | 32726588 | PubTator, text mining | PubMed |
| MIPDH: A Novel Computational Model for Predicting microRNA-mRNA Interactions by DeepWalk on a Heterogeneous Network. | ACS Omega | 2020 | 32715187 | PubTator, text mining | PubMed |
| Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis. | Oncol Rep | 2020 | 32705227 | PubTator, text mining | PubMed |
| Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability. | Eur J Med Chem | 2020 | 32698110 | PubTator, text mining | PubMed |
| The metabotropic glutamate receptor 2/3 antagonist LY341495 improves working memory in adult mice following juvenile social isolation. | Neuropharmacology | 2020 | 32693006 | PubTator, text mining | PubMed |
| The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs. | Front Cell Infect Microbiol | 2020 | 32670889 | PubTator, text mining | PubMed |
| Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder. | J Clin Psychiatry | 2020 | 32663909 | PubTator, text mining | PubMed |
| Tauopathy in the young autistic brain: novel biomarker and therapeutic target. | Transl Psychiatry | 2020 | 32661233 | PubTator, text mining | PubMed |
| Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development. | Biomark Neuropsychiatry | 2020 | 32656540 | PubTator, text mining | PubMed |
| Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing. | Neoplasia | 2020 | 32650224 | PubTator, text mining | PubMed |
| Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanoma. | Hum Mutat | 2020 | 32643855 | PubTator, text mining | PubMed |
| Internalization of AMPA-type Glutamate Receptor in the MIN6 Pancreatic β-cell Line. | Cell Struct Funct | 2020 | 32581155 | PubTator, text mining | PubMed |
| Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism. | Mol Autism | 2020 | 32560742 | PubTator, text mining | PubMed |
| Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. | Signal Transduct Target Ther | 2020 | 32555170 | PubTator, text mining | PubMed |
| Characterization of Group I Metabotropic Glutamate Receptors in Rat and Human Adrenal Glands. | Front Physiol | 2020 | 32536873 | PubTator, text mining | PubMed |
| The effect of mGlu2/3 receptors on synaptic activities to different types of GABAergic interneurons in the anterior cingulate cortex. | Neuropharmacology | 2020 | 32525061 | PubTator, text mining | PubMed |
| Human gene and disease associations for clinical-genomics and precision medicine research. | Clin Transl Med | 2020 | 32508008 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/papers?page=28